Warning letter
Aloha Medicinals Inc. [ARCHIVED]: warning letter of Apr 6, 2010
FDA warning letter UCM208978 · San Francisco District Office
Key facts
| Reference number | UCM208978 |
|---|---|
| Company | Aloha Medicinals Inc. [ARCHIVED] |
| Subject | New Animal Drug/Labeling/Misbranded/Adulterated |
| Issue date | Apr 6, 2010 |
| Posted date | Apr 6, 2010 |
| Issuing office | San Francisco District Office |
| Product type | Drugs |
| CFR sections cited | 101.93(g)(2)(iv) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: